News on Medial

Related News

PB Fintech posts Rs 1,292 Cr revenue and Rs 72 Cr profits in Q3 FY25

EntrackrEntrackr · 7m ago
PB Fintech posts Rs 1,292 Cr revenue and Rs 72 Cr profits in Q3 FY25
Medial

PB Fintech’s revenue increased to Rs 1,292 crore in Q3 FY25 as compared to Rs 871 crore during Q3 FY24, as per the firm’s unaudited consolidated financial results. PB Fintech, the parent company of Policybazaar and Paisabazaar, recorded a 48.3% year-on-year increase in revenue during the third quarter of the ongoing fiscal year (FY25). At the same time, the firm nearly doubled its profits, maintaining strong growth in earnings. Insurance broking formed 87.6% of the total collections which surged by 62.4% to Rs 1,132 crore during Q3 FY25 from Rs 697 crore in Q3 FY24. The income from other operating activities, which include marketing, advertising, consulting, and support services, plunged 8% to Rs 160 crore in the same period. The firm earned Rs 100 crore from non-operating activities including financial income, tallying its overall revenue to Rs 1,392 crore in Q3 FY25, compared to Rs 965 crore in the same quarter of the previous fiscal year. For PB Fintech, employee benefits cost remained the largest cost center forming 37% of the overall expenditure. This cost increased by 22.4% YoY to Rs 487 crore in Q3 FY25 from Rs 398 crore in Q3 FY24. This includes Rs 51 crore as ESOP expense (non-cash). The company’s spending on advertising and promotional grew 34% to Rs 289 crore. Its network, internet, legal, rent, and other overheads pushed its total expenditure to Rs 1,307 crore in Q3 FY25 from Rs 926 crore in Q3 FY24. The significant year-on-year growth helped PB Fintech to post a 94.6% surge in profits to Rs 72 crore in Q3 FY25 from Rs 37 crore in the third quarter of the previous fiscal year. On a unit level, the Gurugram-based firm spent Rs 1.01 to earn a rupee in Q3 FY25. PB Fintech ended the day on January 30 with a share price of Rs 1,659.7 and a total market capitalization of Rs 76,225 crore (approximately $9 billion).

PB Healthcare to raise Rs 1,461 Cr in seed round; no longer subsidiary of PB Fintech

EntrackrEntrackr · 4m ago
PB Healthcare to raise Rs 1,461 Cr in seed round; no longer subsidiary of PB Fintech
Medial

PB Healthcare Services, formerly a wholly-owned subsidiary of PB Fintech Limited, is raising Rs 1,461 crore (approximately $171 million) as part of the first tranche of its seed round. Of the total amount, Rs 539.4 crore has already been infused by PB Fintech Limited, while the remaining capital will be contributed by external investors, according to disclosures filed with the National Stock Exchange (NSE). For context, PB Fintech had earlier passed a resolution to invest up to Rs 696 crore through the purchase of equity shares or preference shares of PB Healthcare Services Private Limited in FY26. As part of the current round, it has already invested Rs 539.4 crore, with the remaining amount yet to be deployed. As per the filings, PB Fintech’s stake in PB Healthcare Services has dropped from 100% to 32.14% following the participation of external investors in the seed round. Previously a wholly-owned subsidiary, PB Healthcare has also created an ESOP pool to attract and retain key talent. The capital infusion is aimed at strengthening the company’s financial position and supporting its growth plans. “The dilution in shareholding is a strategic decision to bring in external investors and create an ESOP pool to attract and retain talent,” the company noted in its filing. Founded in January 2025, PB Healthcare Services set out with an ambitious goal of establishing hospitals with a cumulative capacity of 1,000 beds within its first year. The company plans to launch operations in the National Capital Region (NCR), with a phased expansion into other major metro cities.

Smytten cuts losses by 41% in FY25; revenue slips to Rs 111 Cr

EntrackrEntrackr · 7d ago
Smytten cuts losses by 41% in FY25; revenue slips to Rs 111 Cr
Medial

Smytten cuts losses by 41% in FY25; revenue slips to Rs 111 Cr Smytten, a product discovery and trial platform, improved its expense discipline and significantly narrowed losses, but the revenue decline highlights its continuing struggle to achieve sustainable growth in FY25. The company’s revenue from operations declined 10.5% to Rs 111 crore in FY25 from Rs 124 crore in FY24, according to its provisional financial statement sourced from the Registrar of Companies (RoC). Smytten derives its income largely from product trials and allied services for D2C and FMCG brands. The firm also generates ancillary revenues through brand promotions and partnerships. The company did not provide a revenue breakup in its provisional financial statements. On the expense front, the cost of materials, the firm’s largest expense, declined 17% to Rs 58 crore in FY25 from Rs 70 crore in FY24. Employee benefit expenses fell 9% to Rs 20 crore, while details of other overheads, including marketing, tech, and operational costs, were not disclosed. Overall, the company managed to reduce its total expenses by 21% to Rs 131 crore in FY25 from Rs 165 crore in FY24. The sharper control on expenses helped Smytten cut its losses by 41% to Rs 23.5 crore, as compared to Rs 40 crore in FY24. Its ROCE and EBITDA margin stood at -76.92% and -16.92%, respectively. On a per-unit basis, the firm spent Rs 1.18 to earn a rupee of revenue in the last fiscal year. As of March 2025, the Bengaluru-based company reported current assets worth Rs 67 crore, including Rs 20 crore in cash and bank balances. According to TheKredible, Smytten has raised a total of $22 million of funding till date, having Roots Ventures and Fireside Ventures as its lead investors. The company’s co-founders Siddhartha Nangia and Swagata Sarangi together own 39.32% of the company.

Exclusive: PB Fintech adds new ESOP worth near Rs 2,000 Cr

EntrackrEntrackr · 1y ago
Exclusive: PB Fintech adds new ESOP worth near Rs 2,000 Cr
Medial

Policybazaar and Paisabazaar’s parent PB Fintech has introduced a new ESOP plan worth Rs 1,931 crore (approximately $233 million) under PB Fintech Limited Employees Stock Option Scheme 2024. The board at PB Fintech has passed a resolution to grant 1,14,00,000 employee stock options to its staff, directors and subsidiaries, its regulatory filing accessed from the National Stock Exchange shows. The employee stock under ESOP plan 2024 will be vested after 4 years from the date of granting. According to Entrackr estimates, the new ESOP plan is worth Rs 1,931 crore or $233 million. The above-passed resolution is subject to shareholders approval. PB Fintech has posted Rs 1,010 crore of revenue during the first quarter of the ongoing fiscal year with a steady profit that stood at Rs 60 crore. The firm also showcased robust financial growth with a 34.4% year-on-year revenue increase to Rs 3,438 crore in FY24. Meanwhile, it also turned profitable with Rs 64 crore in the last fiscal year. The ESOP approval was followed by impressive growth in the share price. The firm touched its 52-week high share price of Rs 1,763 on August 20. The company is currently trading at 1,694 (as of 15.37 today) with a total market capitalization of Rs 77,252 crore ($9.3 billion). Last month, the food tech major Zomato also received a shareholder’s nod for its new ESOP plan worth Rs 3,800 crore or $458 million, tallying its total ESOP pool worth $788 million. Among the public companies, Nykaa and TBO Tek also increased their ESOP pool in 2024.

Download the medial app to read full posts, comements and news.